Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Forckenbeckstrasse 6, 52074, Aachen, Germany.
Curr Opin Biotechnol. 2020 Feb;61:15-20. doi: 10.1016/j.copbio.2019.08.012. Epub 2019 Oct 5.
The production of biopharmaceuticals in plant-based systems had faced several challenges that hampered broader adoption of this technology. In recent years, various plant production hosts have been improved by genetic engineering approaches to overcome obstacles with regard to post-translational modifications and integrity of target proteins. Together with optimized extraction and purification processes, those advances have put plant molecular farming in a more competitive position compared to established production systems. Certain biopharmaceuticals can be derived from plant systems with unique desired properties, qualifying them as biobetters.
植物生物制药在生产中面临着一些挑战,这些挑战阻碍了该技术的更广泛应用。近年来,通过遗传工程方法改进了各种植物生产宿主,以克服目标蛋白翻译后修饰和完整性方面的障碍。与优化的提取和纯化工艺相结合,这些进展使植物分子农业在与已建立的生产系统相比更具竞争力。某些生物制药可以从具有独特所需特性的植物系统中获得,将其作为生物类似药。